Santhera Pharmaceuticals Holding AG Logo

Santhera Pharmaceuticals Holding AG | SANN - Profile, Filings, Stock Info & Investor Relations Data

Santhera Pharmaceuticals Holding AG | SANN
Filings & Investor Relations Data
Login to Watchlist

Create a free account or log in.

Country
Switzerland
Founded
2004
Santhera Pharmaceuticals Holding AG (SANN)

About Santhera Pharmaceuticals Holding AG

We are focusing on the development of treatments for neuromuscular and pulmonary diseases that currently lack treatment options, such as Duchenne muscular dystrophy (DMD) and cystic fibrosis (CF).
We have dedicated more than a decade to researching potential treatments in our ongoing mission to make effective medicines available for these often overlooked, life-altering diseases. We are passionate about improving patients’ quality of life and our vision is to be a leader in providing treatments for rare diseases in these areas with high unmet medical needs.

Employees

91

Market Presence

Worldwide

Headquarters

HOHENRAINSTRASSE 24
4133, PRATTELN
Switzerland

Company Video

Video thumbnail
Click to load video from YouTube

Santhera Pharmaceuticals Holding AG (SANN)
Key Financial Data

AI-Powered Financial Insights Coming Soon

We are currently processing the filings for this company to provide automated financial statement analysis, key ratios, and risk summaries. Please check back later!

Unlock Full Company Insights & AI Chat

Create a free account or log in to add companies to your watchlist, access more data, and chat directly with filings using our AI assistant (as shown!).

Santhera Pharmaceuticals Holding AG (SANN)
Filings & Annual Reports
Chat with AI, summarize, and extract data from processed filings! Look for the 'View & AI' button.

Quick Filters:

Advanced Filters

View all types
Filing Information Actions

Insider Trading Activity

N/A (Non-Executive member)
Buy CHF 42,600.00 CHF 1.42 11.01.22
N/A (Executive member)
Buy CHF 14,420.00 CHF 1.44 10.01.22
N/A (Executive member)
Buy CHF 37,000.00 CHF 1.48 05.01.22

Santhera Pharmaceuticals Holding AG (SANN)
Stock & Investor Information

ISINs

CH1276028821

LEI

54930035HAOFTTQH0U85

Stock Exchange Listings

SIX Swiss Exchange

Industry Classification